These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35716124)

  • 21. Palonosetron (Aloxi) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy.
    Musso M; Scalone R; Bonanno V; Crescimanno A; Polizzi V; Porretto F; Bianchini C; Perrone T
    Support Care Cancer; 2009 Feb; 17(2):205-9. PubMed ID: 18839220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis.
    Yokoe T; Hayashida T; Nagayama A; Nakashoji A; Maeda H; Seki T; Takahashi M; Takano T; Abe T; Kitagawa Y
    Oncologist; 2019 Jun; 24(6):e347-e357. PubMed ID: 30333194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal control of acute cisplatin-induced emesis.
    Verweij J; de Wit R; de Mulder PH
    Oncology; 1996 Jun; 53 Suppl 1():56-64. PubMed ID: 8692553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tardive akathisia after long-term metoclopramide treatment].
    Hjelholt AJ; Andersen CU; Steffensen C
    Ugeskr Laeger; 2021 May; 183(21):. PubMed ID: 34060465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metoclopramide-induced supersensitivity psychosis.
    Lu ML; Pan JJ; Teng HW; Su KP; Shen WW
    Ann Pharmacother; 2002 Sep; 36(9):1387-90. PubMed ID: 12196057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study.
    Harder S; Groenvold M; Isaksen J; Sigaard J; Frandsen KB; Neergaard MA; Mondrup L; Herrstedt J
    Support Care Cancer; 2019 Aug; 27(8):2849-2856. PubMed ID: 30552594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metoclopramide induced dystonia in children: two case reports.
    Yis U; Ozdemir D; Duman M; Unal N
    Eur J Emerg Med; 2005 Jun; 12(3):117-9. PubMed ID: 15891443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
    Bosnjak SM; Dimitrijevic J; Djordjevic F
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):180-8. PubMed ID: 27028050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of emesis from multiple-day and high-dose chemotherapy regimens.
    Navari RM
    J Natl Compr Canc Netw; 2007 Jan; 5(1):51-9. PubMed ID: 17239326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
    Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
    Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity.
    Vig S; Seibert L; Green MR
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):77-82. PubMed ID: 24173694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced vomiting in children: An open-label, randomized phase 3 trial.
    Radhakrishnan V; Pai V; Rajaraman S; Mehra N; Ganesan T; Dhanushkodi M; Perumal Kalaiyarasi J; Rajan AK; Selvarajan G; Ranganathan R; Karunakaran P; Sagar TG
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28532. PubMed ID: 32568452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of olanzapine in chemotherapy-induced nausea and vomiting on platinum-based chemotherapy patients: a randomized controlled study.
    Mukhopadhyay S; Kwatra G; Alice K P; Badyal D
    Support Care Cancer; 2017 Jan; 25(1):145-154. PubMed ID: 27591991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe Quetiapine Withdrawal Syndrome with Nausea and Vomiting in a 65-year-old Patient with Psychotic Depression.
    Koch HJ
    Therapie; 2015; 70(6):537-8. PubMed ID: 26242495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Acute Agitation and Aggression in Children and Adolescents with Pro Re Nata Oral Immediate Release Antipsychotics in the Pediatric Emergency Department.
    Yip L; Aeng E; Elbe D
    J Child Adolesc Psychopharmacol; 2020 Nov; 30(9):534-541. PubMed ID: 33035069
    [No Abstract]   [Full Text] [Related]  

  • 37. The Use, Safety, and Efficacy of Olanzapine in a Level I Pediatric Trauma Center Emergency Department Over a 10-Year Period.
    Cole JB; Klein LR; Strobel AM; Blanchard SR; Nahum R; Martel ML
    Pediatr Emerg Care; 2020 Feb; 36(2):70-76. PubMed ID: 28697164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice.
    Ithimakin S; Runglodvatana K; Nimmannit A; Akewanlop C; Srimuninnimit V; Keerativitayanan N; Soparattanapaisarn N; Laocharoenkeat A
    Support Care Cancer; 2012 Apr; 20(4):849-55. PubMed ID: 21505898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of long-term antipsychotics treatment on body weight: A population-based cohort study.
    Bazo-Alvarez JC; Morris TP; Carpenter JR; Hayes JF; Petersen I
    J Psychopharmacol; 2020 Jan; 34(1):79-85. PubMed ID: 31724905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Phase II study of palonosetron, aprepitant, dexamethasone and olanzapine for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in patients with thoracic malignancy.
    Nakashima K; Murakami H; Yokoyama K; Omori S; Wakuda K; Ono A; Kenmotsu H; Naito T; Nishiyama F; Kikugawa M; Kaneko M; Iwamoto Y; Koizumi S; Mori K; Isobe T; Takahashi T
    Jpn J Clin Oncol; 2017 Sep; 47(9):840-843. PubMed ID: 28633504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.